Featured News

Join us at the Columbia University Celiac Connect Continuing Medical Education- April 1, and UChicago Neurological and Psychological Implications in Celiac Disease- April 23.

The Celiac Disease Foundation is sponsoring the Columbia University Celiac Disease Center Livestream International Symposium. Join us on Friday April 8 - Saturday April 9.

The Celiac Disease Foundation's research grant to the University of California, Davis, funds the development of celiac disease-safe wheat varieties. Dr. Jorge Dubcovsky and Dr. Wenjun Zhang submitted the grant’s first six-month report detailing promising advances.

For adults with celiac disease and non-celiac gluten sensitivity, the microbes in your gut do not influence how sensitive you are to gluten, a recent study found.

Researchers found that children initially diagnosed with potential celiac disease had a high risk of developing celiac disease.

A few highlights from research studies published in peer-reviewed journals in the last few months are products of the research grants CDF awarded.

Join the Solutions for Celiac Study where you get access to blood testing, symptom tracking tools, and celiac specialists focused on your disease.

Anokion SA announced successful completion of its Phase 1 clinical trial evaluating KAN-101 for the treatment of celiac disease, with promising results.

A study from the University of Chicago has demonstrated that B-cells are required for the development of villous atrophy (intestinal damage) in celiac disease. This finding provides support for the exploration of B-cell–directed therapies for the treatment of celiac disease.

Celiac disease patients are at an increased risk, albeit small, of cancer, and the findings from these studies confirm the importance of a healthy immune system in cancer prevention. For patients with celiac disease, adhering to a strict, gluten-free diet is critical to maintaining a healthy immune system.